BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 8866227)

  • 21. The use of fluorescent in situ hybridization for detection of the t(2;5)(p23;q35) translocation in anaplastic large-cell lymphoma.
    Johnson PW; Leek J; Swinbank K; Angus B; Roberts P; Markham AF; Selby PJ; MacLennan KA
    Ann Oncol; 1997; 8 Suppl 2():65-9. PubMed ID: 9209644
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ATIC-ALK: A novel variant ALK gene fusion in anaplastic large cell lymphoma resulting from the recurrent cryptic chromosomal inversion, inv(2)(p23q35).
    Colleoni GW; Bridge JA; Garicochea B; Liu J; Filippa DA; Ladanyi M
    Am J Pathol; 2000 Mar; 156(3):781-9. PubMed ID: 10702393
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The (2;5)(p23;q35) translocation in cell lines derived from malignant lymphomas: absence of t(2;5) in Hodgkin-analogous cell lines.
    Dirks WG; Zaborski M; Jäger K; Challier C; Shiota M; Quentmeier H; Drexler HG
    Leukemia; 1996 Jan; 10(1):142-9. PubMed ID: 8558920
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The cryptic inv(2)(p23q35) defines a new molecular genetic subtype of ALK-positive anaplastic large-cell lymphoma.
    Wlodarska I; De Wolf-Peeters C; Falini B; Verhoef G; Morris SW; Hagemeijer A; Van den Berghe H
    Blood; 1998 Oct; 92(8):2688-95. PubMed ID: 9763551
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nucleophosmin (NPM) gene rearrangements in Ki-1-positive lymphomas.
    Bullrich F; Morris SW; Hummel M; Pileri S; Stein H; Croce CM
    Cancer Res; 1994 Jun; 54(11):2873-7. PubMed ID: 8187071
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The monoclonal antibody ALK1 identifies a distinct morphological subtype of anaplastic large cell lymphoma associated with 2p23/ALK rearrangements.
    Pittaluga S; Wlodarska I; Pulford K; Campo E; Morris SW; Van den Berghe H; De Wolf-Peeters C
    Am J Pathol; 1997 Aug; 151(2):343-51. PubMed ID: 9250148
    [TBL] [Abstract][Full Text] [Related]  

  • 27. NPM/ALK fusion mRNA expression in Hodgkin and Reed-Sternberg cells is rare but does occur: results from single-cell cDNA analysis.
    Trümper L; Daus H; Merz H; von Bonin F; Loftin U; Cochlovius C; Möller P; Feller AC; Pfreundschuh M
    Ann Oncol; 1997; 8 Suppl 2():83-7. PubMed ID: 9209648
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular analysis of the NPM-ALK rearrangement in Hodgkin's disease.
    Xerri L; Parc P; Hassoun J; Birnbaum D
    J Pathol; 1996 Feb; 178(2):128-32. PubMed ID: 8683377
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Detection of anaplastic lymphoma kinase (ALK) and nucleolar protein nucleophosmin (NPM)-ALK proteins in normal and neoplastic cells with the monoclonal antibody ALK1.
    Pulford K; Lamant L; Morris SW; Butler LH; Wood KM; Stroud D; Delsol G; Mason DY
    Blood; 1997 Feb; 89(4):1394-404. PubMed ID: 9028963
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diversity of genomic breakpoints in TFG-ALK translocations in anaplastic large cell lymphomas: identification of a new TFG-ALK(XL) chimeric gene with transforming activity.
    Hernández L; Beà S; Bellosillo B; Pinyol M; Falini B; Carbone A; Ott G; Rosenwald A; Fernández A; Pulford K; Mason D; Morris SW; Santos E; Campo E
    Am J Pathol; 2002 Apr; 160(4):1487-94. PubMed ID: 11943732
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Detection of t(2;5) in anaplastic large cell lymphoma: comparison of immunohistochemical studies, FISH, and RT-PCR in paraffin-embedded tissue.
    Cataldo KA; Jalal SM; Law ME; Ansell SM; Inwards DJ; Fine M; Arber DA; Pulford KA; Strickler JG
    Am J Surg Pathol; 1999 Nov; 23(11):1386-92. PubMed ID: 10555007
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular Screening in Anaplastic Lymphoma Kinase-Positive Anaplastic Large Cell Lymphoma: Anaplastic Lymphoma Kinase Analysis, Next-Generation Sequencing Fusion Gene Detection, and T-Cell Receptor Immunoprofiling.
    Kalinova M; Mrhalova M; Kabickova E; Svaton M; Skotnicova A; Prouzova Z; Krenova Z; Kolenova A; Divoka M; Fronkova E; Kodet R
    Mod Pathol; 2024 Mar; 37(3):100428. PubMed ID: 38266918
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Involvement of Grb2 adaptor protein in nucleophosmin-anaplastic lymphoma kinase (NPM-ALK)-mediated signaling and anaplastic large cell lymphoma growth.
    Riera L; Lasorsa E; Ambrogio C; Surrenti N; Voena C; Chiarle R
    J Biol Chem; 2010 Aug; 285(34):26441-50. PubMed ID: 20554525
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nucleophosmin-anaplastic lymphoma kinase of anaplastic large-cell lymphoma recruits, activates, and uses pp60c-src to mediate its mitogenicity.
    Cussac D; Greenland C; Roche S; Bai RY; Duyster J; Morris SW; Delsol G; Allouche M; Payrastre B
    Blood; 2004 Feb; 103(4):1464-71. PubMed ID: 14563642
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of the nucleophosmin (NPM) portion of the non-Hodgkin's lymphoma-associated NPM-anaplastic lymphoma kinase fusion protein in oncogenesis.
    Bischof D; Pulford K; Mason DY; Morris SW
    Mol Cell Biol; 1997 Apr; 17(4):2312-25. PubMed ID: 9121481
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pathobiology of ALK+ anaplastic large-cell lymphoma.
    Amin HM; Lai R
    Blood; 2007 Oct; 110(7):2259-67. PubMed ID: 17519389
    [TBL] [Abstract][Full Text] [Related]  

  • 37. IGF-IR tyrosine kinase interacts with NPM-ALK oncogene to induce survival of T-cell ALK+ anaplastic large-cell lymphoma cells.
    Shi P; Lai R; Lin Q; Iqbal AS; Young LC; Kwak LW; Ford RJ; Amin HM
    Blood; 2009 Jul; 114(2):360-70. PubMed ID: 19423729
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The t(2;5)-associated p80 NPM/ALK fusion protein in nodal and cutaneous CD30+ lymphoproliferative disorders.
    Su LD; Schnitzer B; Ross CW; Vasef M; Mori S; Shiota M; Mason DY; Pulford K; Headington JT; Singleton TP
    J Cutan Pathol; 1997 Nov; 24(10):597-603. PubMed ID: 9449486
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lymphomas expressing ALK fusion protein(s) other than NPM-ALK.
    Falini B; Pulford K; Pucciarini A; Carbone A; De Wolf-Peeters C; Cordell J; Fizzotti M; Santucci A; Pelicci PG; Pileri S; Campo E; Ott G; Delsol G; Mason DY
    Blood; 1999 Nov; 94(10):3509-15. PubMed ID: 10552961
    [TBL] [Abstract][Full Text] [Related]  

  • 40. NPM/ALK gene fusion transcripts identify a distinct subgroup of null type Ki-1 positive anaplastic large cell lymphomas.
    Simonitsch I; Panzer-Gruemayer ER; Ghali DW; Zoubek A; Radaszkiewicz T; Gadner H; Kovar H
    Br J Haematol; 1996 Mar; 92(4):866-71. PubMed ID: 8616079
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.